Regulation - China

Filter

Current filters:

China

Popular Filters

China’s FDA approves Chipscreen’s Epidaza

China’s FDA approves Chipscreen’s Epidaza

12-01-2015

Chinese biotech firm Chipscreen Biosciences has received regulatory approval of Epidaza (chidamide),…

BiotechnologychidamideChinaChipscreen BiosciencesEpidazaOncologyRegulation

China’s new regulatory process could cause delays, RDPAC warns

China’s new regulatory process could cause delays, RDPAC warns

09-12-2014

Concerns have been raised in China that regulatory delays could defer the introduction of new drugs into…

BloombergChinaPharmaceuticalR&D-Based Pharmaceutical Association CommitteeRegulation

A top-20 pharma to utilize Xyntek-Antares serializing for China

A top-20 pharma to utilize Xyntek-Antares serializing for China

08-12-2014

A top 20 multi-national pharmaceutical research and manufacturer is utilizing the Xyntek-Antares solution…

ChinaPharmaceuticalProductionRegulationXyntek

Meaningful discussions at 9th International Summit of Heads of Medicines Regulatory Agencies

24-11-2014

Wu Zhen, Vice Minister of China Food and Drug Administration (CFDA), met with the delegates of Canada,…

BrazilCanadaChinaPharmaceuticalProductionRegulation

Stronger punishments for production and sale of fake drugs in China

18-11-2014

Chinese authorities will hand out harsher punishment for the production and sale of fake and substandard…

ChinaMarkets & MarketingPharmaceuticalProductionRegulation

Positive WHO assessment of China’s vaccines regulatory authority

Positive WHO assessment of China’s vaccines regulatory authority

06-07-2014

China's national vaccine supervision system has met or passed all the standard requirements of the World…

ChinaPharmaceuticalRegulationVaccines

China’s FDA warns of on-line sales of fake cancer drug

China’s FDA warns of on-line sales of fake cancer drug

12-06-2014

China's drug administration on Wednesday warned consumers not to purchase illegally imported cancer drugs…

ChinaMarkets & MarketingOncologyPharmaceuticalRegulation

UK’s MHRA seizes £8.6 million of counterfeit, controlled and unlicensed medicines

26-05-2014

The UK Medicines and Healthcare Products Regulatory Agency (MHRA) revealed last week that it has seized…

ChinaIndiaMarkets & MarketingPharmaceuticalRegulationUK

China FDA reports increase in adverse drug reaction reports

21-05-2014

The China Food and Drug Administration (CFDA) recently released the 2013 Annual Report for National Adverse…

ChinaPharmaceuticalRegulation

Global Fund taps pharmaceutical expertise in China

02-04-2014

The Global Fund is deepening its partnership with China by tapping the expertise of Chinese pharmaceutical…

Anti-viralsAntibiotics and Infectious diseasesChinaGlobalMarkets & MarketingPharmaceuticalProductionRegulation

Chinese health professionals' conduct to be regulated

29-01-2014

China's National Health and Family Planning Commission this week issued a draft regulation on health…

Asia-PacificChinaPharmaceuticalRegulation

China’s pharma blacklist could be weakened by inconsistent enforcement

China’s pharma blacklist could be weakened by inconsistent enforcement

29-01-2014

Though Chinese regulators are pushing ahead with a blacklisting system to combat bribery in pharmaceutical…

ChinaLegalPharmaceuticalRegulation

US global share of biomedical research spending declines, as Asia gains

02-01-2014

The USA’s global share of biomedical research spending fell from 51% in 2007 to 45% in 2012, while…

Asia-PacificChinaFinancialNorth AmericaPharmaceuticalRegulationResearchUSA

Punishments for Chinese doctors who accept kickbacks from pharma

Punishments for Chinese doctors who accept kickbacks from pharma

27-12-2013

Doctors in China who take kickbacks from pharmaceutical companies or accept "red envelopes" from patients…

Asia-PacificChinaMarkets & MarketingPharmaceuticalRegulation

China bans BioKangtai hepatitis B vaccine

26-12-2013

Chinese authorities on Friday issued a circular to ban the use of the recombinant hepatitis B vaccine…

Anti-viralsAsia-PacificBioKangtaiChinaHealthcarePharmaceuticalRegulationVaccines

Russia, Ukraine and the Baltic states increasing in importance on the contract manufacturing market

Russia, Ukraine and the Baltic states increasing in importance on the contract manufacturing market

11-12-2013

Russia seems to be an attractive country for pharmaceutical contract manufacturing, chiefly because of…

Asia-PacificChinaEastern EuropeGenericsIndiaProductionRegulationRussiaUkraine

COMPANY SPOTLIGHT

Menarini

Back to top